Atara Biotherapeutics ATRA
NASDAQ ATRA
$9.43 +0.08 (+0.86%)
At close: Oct 22, 2026 · 4:00 PM EDT

Atara Biotherapeutics (ATRA) Operating Margin (2021 - 2026)

Updated

Atara Biotherapeutics' Operating Margin was -749.21% in Q2 2026, down 767.40 percentage points from 18.19% a year earlier and down 96.30 percentage points from the prior quarter.

Analysis

Atara Biotherapeutics (ATRA) Operating Margin (2021 - 2026) Analysis & Trends

On a trailing twelve-month basis, Atara Biotherapeutics' Operating Margin was -229.67% through Jun 30, 2026, down 233.93 percentage points year-over-year; for FY2025, it was 29.69%, up 94.40 percentage points from FY2024.

  • Operating Margin shows a four-year change of +1703.55 percentage points (FY2021 to FY2025).
  • In earlier years, Operating Margin was -64.71% in FY2024 (+3154.77 pp), -3219.48% in FY2023 (-2778.42 pp), -441.06% in FY2022 (+1232.80 pp) and -1673.85% in FY2021.
  • The Q2 2026 figure marks the lowest quarterly Operating Margin since Q4 2023.
  • Compared with a year earlier, Operating Margin has declined for four straight quarters, with an average year-over-year change of +397.21 percentage points over the last eight quarters.
  • The best year-over-year quarter for Operating Margin over five years was Q4 2023 (a gain of 29049.07 percentage points); the worst was Q4 2022 (a drop of 29221.82 percentage points).
  • Per Business Quant data, ATRA's Operating Margin in the three quarters before Q2 2026 was -652.91% (Q1 2026), -160.69% (Q4 2025) and -103.50% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 24.35%
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 37.86%
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -3.52%
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 32.97%
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 20.57%
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 34.95%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -133.21%
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 28.37%
10 Atara Biotherapeutics 141.16 Mn 131.26 Mn 439,000.00 -749.21%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -749.21%
Mar 31, 2026 -652.91%
Dec 31, 2025 -160.69%
Sep 30, 2025 -103.50%
Jun 30, 2025 18.19%
Mar 31, 2025 39.53%
Dec 31, 2024 -37.26%
Sep 30, 2024 -54.14%
Jun 30, 2024 -63.66%
Mar 31, 2024 -114.22%
Dec 31, 2023 -1,410.21%
Sep 30, 2023 -3,255.94%
Jun 30, 2023 -7,462.28%
Mar 31, 2023 -6,118.92%
Dec 31, 2022 -30,459.27%
Sep 30, 2022 -1,897.78%
Jun 30, 2022 -62.30%
Mar 31, 2022 -1,206.18%
Dec 31, 2021 -1,237.45%
Sep 30, 2021 -1,579.37%
API Access

Atara Biotherapeutics Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=ATRA&period=max&api_key=YOUR_API_KEY